Relevance of dietary iron intake and bioavailability in the management of HFE hemochromatosis: A systematic review

American Journal of Clinical Nutrition

Volumn 98, Issue 2, 2013, Pages 468-479

  Moretti, Diego ^a,c   Van Doorn, Gerrigje M ^a   Swinkels, Dorine W ^b   Melse Boonstra, Alida ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b ETH ZURICH   (Switzerland)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; HEPCIDIN; IRON;

BIOAVAILABILITY; GENE MUTATION; HEMOCHROMATOSIS; HEMOGLOBIN DETERMINATION; HETEROZYGOTE; INFORMATION RETRIEVAL; IRON ABSORPTION; IRON BALANCE; IRON INTAKE; LONGITUDINAL STUDY; PHLEBOTOMY; QUALITY OF LIFE; REVIEW; TEST MEAL;

ABSORPTION; ANTIMICROBIAL CATIONIC PEPTIDES; BIOLOGICAL AVAILABILITY; DIET; HEMOCHROMATOSIS; HETEROZYGOTE; HUMANS; IRON, DIETARY; MUTATION; PENETRANCE;

EID: 84881243027     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.112.048264     Document Type: Review

References (65)

1. Janssen MC, Swinkels DW. Hereditary haemochromatosis. Best Pract Res Clin Gastroenterol 2009;23:171-83.
2. Walters GO, Jacobs A, Worwood M, Trevett D, Thomson W. Ironabsorption in normal subjects and patients with idiopathic hemochromatosis - relationship with serum ferritin concentration. Gut 1975;16: 188-92.
3. Lynch SR, Skikne BS, Cook JD. Food iron-absorption in idiopathic hemochromatosis. Blood 1989;74:2187-93.
4. Swinkels DW, Janssen MCH, Bergmans J, Marx JJM. Hereditary hemochromatosis: genetic complexity and new diagnostic approaches. Clin Chem 2006;52:950-68.
5. van Bokhoven MA, van Deursen CT, Swinkels DW. Diagnosis and management of hereditary haemochromatosis. BMJ 2011;342:c7251.
6. Merryweather-Clarke AT, Pointon JJ, Shearman JD, Robson KJ. Global prevalence of putative haemochromatosis mutations. J Med Genet 1997;34:275-8.
7. Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T. Penetrance of 845g/ a (c282y) hfe hereditary haemochromatosis mutation in the USA. Lancet 2002;359:211-8.
8. Allen KJ, Gurrin LC, Constantine CC, Osborne NJ, Delatycki MB, Nicoll AJ, McLaren CE, Bahlo M, Nisselle AE, Vulpe CD, et al. Ironoverload- related disease in HFE hereditary hemochromatosis. N Engl J Med 2008;358:221-30.
9. McCune CA. Sex, drugs, and "heavy metal": does diet also matter in the clinical expression of hereditary hemochromatosis? Mayo Clin Proc 2008;83:526-8 .
10. Hallberg L, Hulten L, Gramatkovski E. Iron absorption from the whole diet in men: how effective is the regulation of iron absorption? Am J Clin Nutr 1997;66:347-56.
11. Sharp PA. Intestinal iron absorption: regulation by dietary & systemic factors. Int J Vitam Nutr Res 2010;80:231-42.
12. Anderson GJ, Frazer DM, McKie AT, Vulpe CD, Smith A. Mechanisms of haem and non-haem iron absorption: lessons from inherited disorders of iron metabolism. Biometals 2005;18:339-48.
13. Le Blanc S, Garrick MD, Arredondo M. Heme carrier protein 1 transports heme and is involved in heme-Fe metabolism. Am J Physiol Cell Physiol 2012;302:C1780-5.
14. Kroot JJ, Tjalsma H, Fleming RE, Swinkels DW. Hepcidin in human iron disorders: diagnostic implications. Clin Chem 2011;57:1650-69.
15. Weiss G. Genetic mechanisms and modifying factors in hereditary hemochromatosis. Nat Rev Gastroenterol Hepatol 2010;7:50-8.
16. Zoller H, Pietrangelo A, Vogel W, Weiss G. Duodenal metaltransporter (DMT-1, NRAMP-2) expression in patients with hereditary haemochromatosis. Lancet 1999;353:2120-3.
17. Zoller H, Koch RO, Theurl I, Obrist P, Pietrangelo A, Montosi G, Haile DJ, Vogel W, Weiss G. Expression of the duodenal iron transporters divalent-metal transporter 1 and ferroportin 1 in iron deficiency and iron overload. Gastroenterology 2001;120:1412-9.
18. Stuart KA, Anderson GJ, Frazer DM, Powell LW, McCullen M, Fletcher LM, Crawford DH. Duodenal expression of iron transport molecules in untreated haemochromatosis subjects. Gut 2003;52:953-9.
19. Zoller H, Theurl I, Koch RO, McKie AT, Vogel W, Weiss G. Duodenal cytochrome b and hephaestin expression in patients with iron deficiency and hemochromatosis. Gastroenterology 2003;125:746-54.
20. van Dijk BA, Laarakkers CM, Klaver SM, Jacobs EM, van Tits LJ, Janssen MC, Swinkels DW. Serum hepcidin levels are innately low in HFE-related haemochromatosis but differ between C282Y-homozygotes with elevated and normal ferritin levels. Br J Haematol 2008;142:979-85.
21. Zimmermann MB, Chaouki N, Hurrell RF. Iron deficiency due to consumption of a habitual diet low in bioavailable iron: a longitudinal cohort study in Moroccan children. Am J Clin Nutr 2005;81:115-21.
22. Zimmermann MB, Hurrell RF. Nutritional iron deficiency. Lancet 2007;370:511-20.
23. Brissot P, Troadec MB, Bardou-Jacquet E, Le Lan C, Jouanolle AM, Deugnier Y, Loreal O. Current approach to hemochromatosis. Blood Rev 2008;22:195-210.
24. Adams PC, Barton JC. How I treat hemochromatosis. Blood 2010;116: 317-25.
25. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, Dormishian F, Domingo R Jr, Ellis MC, Fullan A, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996;13:399-408.
26. Zimmermann MB, Troesch B, Biebinger R, Egli I, Zeder C, Hurrell RF. Plasma hepcidin is a modest predictor of dietary iron bioavailability in humans, whereas oral iron loading, measured by stableisotope appearance curves, increases plasma hepcidin. Am J Clin Nutr 2009;90:1280-7.
27. Swinkels DW, Girelli D, Laarakkers C, Kroot J, Campostrini N, Kemna EH, Tjalsma H. Advances in quantitative hepcidin measurements by time-of-flight mass spectrometry. PLoS ONE 2008;3:e2706.
28. Kroot JJ, Laarakkers CM, Geurts-Moespot AJ, Grebenchtchikov N, Pickkers P, van Ede AE, Peters HP, van Dongen-Lases E, Wetzels JF, Sweep FC, et al. Immunochemical and mass-spectrometry-based serum hepcidin assays for iron metabolism disorders. Clin Chem 2010;56:1570-9.
29. Smith PM, Godfrey BE, Williams R. Iron absorption in idiopathic haemochromatosis and its measurement using a whole-body counter. Clin Sci 1969;37:519-31.
30. Williams R, Manenti F, Williams HS, Pitcher CS. Iron absorption in idiopathic haemochromatosis before, during, and after venesection therapy. BMJ 1966;2:78-81.
31. Bezwoda WR, Disler PB, Lynch SR, Charlton RW, Torrance JD, Derman D, Bothwell TH, Walker RB, Mayet F. Patterns of food iron absorption in iron-deficient white and Indian subjects and in venesected haemochromatotic patients. Br J Haematol 1976;33:425-36.
32. Valberg LS, Ghent CN, Lloyd DA, Frei JV, Chamberlain MJ. Ironabsorption in idiopathic hemochromatosis - relationship to serum ferritin concentration in asymptomatic relatives. Clin Invest Med 1979;2: 17-22.
33. Bezwoda WR, Bothwell TH, Derman DP, MacPhail AP, Torrance JD, Charlton RW. Effect of diet on the rate of iron accumulation in idiopathic haemochromatosis. S Afr Med J 1981;59:219-22.
34. Kaltwasser JP, Werner E, Schalk K, Hansen C, Gottschalk R, Seidl C. Clinical trial on the effect of regular tea drinking on iron accumulation in genetic haemochromatosis. Gut 1998;43:699-704.
35. Hutchinson C, Conway RE, Bomford A, Hider RC, Powell JJ, Geissler CA. Post-prandial iron absorption in humans: comparison between HFE genotypes and iron deficiency anaemia. Clin Nutr 2008;27:258- 63.
36. Olsson KS, Vaisanen M, Konar J, Bruce A. The effect of withdrawal of food iron fortification in Sweden as studied with phlebotomy in subjects with genetic hemochromatosis. Eur J Clin Nutr 1997;51:782-6.
37. Hutchinson C, Geissler CA, Powell JJ, Bomford A. Proton pump inhibitors suppress absorption of dietary non-haem iron in hereditary haemochromatosis. Gut 2007;56:1291-5.
38. Scotet V, Merour MC, Mercier AY, Chanu B, Le Faou T, Raguenes O, Le Gac G, Mura C, Nousbaum JB, Ferec C. Hereditary hemochromatosis: effect of excessive alcohol consumption on disease expression in patients homozygous for the c282y mutation. Am J Epidemiol 2003; 158:129-34.
39. Greenwood DC, Cade JE, Moreton JA, O'Hara B, Burley VJ, Randerson-Moor JA, Kukalizch K, Thompson D, Worwood M, Bishop DT. HFE genotype modifies the influence of heme iron intake on iron status. Epidemiology 2005;16:802-5.
40. Cade JE, Moreton JA, O'Hara B, Greenwood DC, Moor J, Burley VJ, Kukalizch K, Bishop DT, Worwood M. Diet and genetic factors associated with iron status in middle-aged women. Am J Clin Nutr 2005; 82:813-20.
41. van der A DL, Peeters PH, Grobbee DE, Roest M, Voorbij HA, van der Schouw YT. HFE genotypes and dietary heme iron: no evidence of strong gene-nutrient interaction on serum ferritin concentrations in middle-aged women. Nutr Metab Cardiovasc Dis 2006;16:60-8.
42. McCune CA, Ravine D, Carter K, Jackson HA, Hutton D, Hedderich J, Krawczak M,Worwood M. Iron loading and morbidity among relatives of HFE c282y homozygotes identified either by population genetic testing or presenting as patients. Gut 2006;55:554-62.
43. Milward EA, Baines SK, Knuiman MW, Bartholomew HC, Divitini ML, Ravine DG, Bruce DG, Olynyk JK. Noncitrus fruits as novel dietary environmental modifiers of iron stores in people with or without HFE gene mutations. Mayo Clin Proc 2008;83:543-9.
44. Jacobs EM, Hendriks JC, van Deursen CT, Kreeftenberg HG, de Vries RA, Marx JJ, Stalenhoef AF, Verbeek AL, Swinkels DW. Severity of iron overload of proband determines serum ferritin levels in families with HFE-related hemochromatosis: the hemochromatosis family study. J Hepatol 2009;50:174-83.
45. Gordeuk VR, Lovato L, Barton J, Vitolins M, McLaren G, Acton R, McLaren C, Harris E, Speechley M, Eckfeldt JH, et al. Dietary iron intake and serum ferritin concentration in 213 patients homozygous for the hfec282y hemochromatosis mutation. Can J Gastroenterol 2012;26: 345-9.
46. Hallberg L, Brune M, Rossander L. Iron absorption in man: ascorbic acid and dose-dependent inhibition by phytate. Am J Clin Nutr 1989; 49:140-4.
47. Moretti D, Zimmermann MB, Wegmuller R, Walczyk T, Zeder C, Hurrell RF. Iron status and food matrix strongly affect the relative bioavailability of ferric pyrophosphate in humans. Am J Clin Nutr 2006;83:632-8.
48. Hurrell RF, Reddy M, Cook JD. Inhibition of non-haem iron absorption in man by polyphenolic-containing beverages. Br J Nutr 1999;81:289- 95.
49. Thankachan P, Walczyk T, Muthayya S, Kurpad AV, Hurrell RF. Iron absorption in young indian women: the interaction of iron status with the influence of tea and ascorbic acid. Am J Clin Nutr 2008;87:881-6.
50. Adams PC, Kertesz AE, Valberg LS. Rate of iron reaccumulation following iron depletion in hereditary hemochromatosis - implications for venesection therapy. J Clin Gastroenterol 1993;16:207-10.
51. Gurrin LC, Osborne NJ, Constantine CC, McLaren CE, English DR, Gertig DM, Delatycki MB, Southey MC, Hopper JL, Giles GG, et al. The natural history of serum iron indices for hfe c282y homozygosity associated with hereditary hemochromatosis. Gastroenterology 2008; 135:1945-52.
52. Adams PC. The natural history of untreated hfe-related hemochromatosis. Acta Haematol 2009;122:134-9.
53. Cook JD. Diagnosis and management of iron-deficiency anaemia. Best Pract Res Clin Haematol 2005;18:319-32.
54. Finch CA, Bellotti V, Stray S, Lipschitz DA, Cook JD, Pippard MJ, Huebers HA. Plasma ferritin determination as a diagnostic tool. West J Med 1986;145:657-63.
55. Tao M, Pelletier DL. The effect of dietary iron intake on the development of iron overload among homozygotes for haemochromatosis. Public Health Nutr 2009;12:1823-9.
56. Swinkels DW, Drenth JP. Hepcidin in the management of patients with mild non-hemochromatotic iron overload: fact or fiction? J Hepatol 2008;49:680-5.
57. Roe MA, Collings R, Dainty JR, Swinkels DW, Fairweather-Tait SJ. Plasma hepcidin concentrations significantly predict interindividual variation in iron absorption in healthy men. Am J Clin Nutr 2009;89: 1088-91.
58. Hultén L, Gramatkovski E, Gleerup A, Hallberg L. Iron absorption from the whole diet. Relation to meal composition, iron requirements and iron stores. Eur J Clin Nutr 1995;49:794-808.
59. Zimmermann MB, Wegmueller R, Zeder C, Chaouki N, Rohner F, Saissi M, Torresani T, Hurrell RF. Dual fortification of salt with iodine and micronized ferric pyrophosphate: a randomized, double-blind, controlled trial. Am J Clin Nutr 2004;80:952-9.
60. Zimmermann MB, Zeder C, Chaouki N, Saad A, Torresani T, Hurrell RF. Dual fortification of salt with iodine and microencapsulated iron: a randomized, double-blind, controlled trial in Moroccan schoolchildren. Am J Clin Nutr 2003;77:425-32.
61. Andersson M, Theis W, Zimmermann MB, Foman JT, Jakel M, Duchateau GS, Frenken LG, Hurrell RF. Random serial sampling to evaluate efficacy of iron fortification: a randomized controlled trial of margarine fortification with ferric pyrophosphate or sodium iron edetate. Am J Clin Nutr 2010;92:1094-104.
62. Panel on Micronutrients. Iron. In: Institute of Medicine, ed. Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc.Washington, DC: The National Academies Press, 2001.
63. Bacon BR, Adams PC, Kowdley KV, Powell LW, Tavill AS. Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology 2011;54:328-43.
64. Piperno A, Girelli D, Nemeth E, Trombini P, Bozzini C, Poggiali E, Phung Y, Ganz T, Camaschella C. Blunted hepcidin response to oral iron challenge in hfe-related hemochromatosis. Blood 2007;110:4096- 100.
65. Greenfield S, Kaplan SH, Ware JE Jr, Yano EM, Frank HJ. Patients' participation in medical care: effects on blood sugar control and quality of life in diabetes. J Gen Intern Med 1988;3:448-57.